Bank of America’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,109
| Closed | -$311 | – | 5752 |
|
|
2025
Q4 | $311 | Sell |
3,109
-8,561
| -73% | -$5.44K | ﹤0.01% | 6637 |
|
|
2025
Q3 | $7.05K | Sell |
11,670
-6,497
| -36% | -$3.06K | ﹤0.01% | 7258 |
|
|
2025
Q2 | $5.65K | Sell |
18,167
-26,245
| -59% | -$10.2K | ﹤0.01% | 7280 |
|
|
2025
Q1 | $21.7K | Sell |
44,412
-123,003
| -73% | -$72.4K | ﹤0.01% | 6953 |
|
|
2024
Q4 | $143K | Sell |
167,415
-147,491
| -47% | -$925K | ﹤0.01% | 6254 |
|
|
2024
Q3 | $2.68M | Buy |
314,906
+85,044
| +37% | +$501K | ﹤0.01% | 4317 |
|
|
2024
Q2 | $1.07M | Buy |
229,862
+194,317
| +547% | +$920K | ﹤0.01% | 4865 |
|
|
2024
Q1 | $242K | Sell |
35,545
-9,086
| -20% | -$40.8K | ﹤0.01% | 5787 |
|
|
2023
Q4 | $150K | Buy |
44,631
+44,403
| +19,475% | +$111K | ﹤0.01% | 6221 |
|
|
2023
Q3 | $567 | Buy |
228
+227
| +22,700% | +$374 | ﹤0.01% | 7303 |
|
|
2023
Q2 | $1 | Sell |
1
-364
| -100% | -$483 | ﹤0.01% | 7655 |
|
|
2023
Q1 | $296 | Buy |
365
+236
| +183% | +$232 | ﹤0.01% | 7402 |
|
|
2022
Q4 | $98 | Sell |
129
-329
| -72% | -$260 | ﹤0.01% | 7673 |
|
|
2022
Q3 | $0 | Sell |
458
-3,934
| -90% | -$4.72K | ﹤0.01% | 7804 |
|
|
2022
Q2 | $4K | Sell |
4,392
-15,796
| -78% | -$25.9K | ﹤0.01% | 7635 |
|
|
2022
Q1 | $43K | Sell |
20,188
-15,843
| -44% | -$42.4K | ﹤0.01% | 7232 |
|
|
2021
Q4 | $322K | Buy |
36,031
+21,488
| +148% | +$282K | ﹤0.01% | 6195 |
|
|
2021
Q3 | $242K | Buy |
14,543
+1,666
| +13% | +$28.8K | ﹤0.01% | 6180 |
|
|
2021
Q2 | $268K | Buy |
12,877
+1,495
| +13% | +$28.3K | ﹤0.01% | 5871 |
|
|
2021
Q1 | $213K | Buy |
11,382
+6,625
| +139% | +$143K | ﹤0.01% | 5987 |
|
|
2020
Q4 | $105K | Sell |
4,757
-501
| -10% | -$10.4K | ﹤0.01% | 5958 |
|
|
2020
Q3 | $109K | Sell |
5,258
-2,051
| -28% | -$53.3K | ﹤0.01% | 5654 |
|
|
2020
Q2 | $264K | Buy |
7,309
+5,076
| +227% | +$212K | ﹤0.01% | 5064 |
|
|
2020
Q1 | $73K | Sell |
2,233
-285
| -11% | -$11.5K | ﹤0.01% | 5690 |
|
|
2019
Q4 | $69K | Buy |
2,518
+1,592
| +172% | +$27.3K | ﹤0.01% | 6146 |
|
|
2019
Q3 | $10K | Buy |
+926
| New | +$8.74K | ﹤0.01% | 6718 |
|
Bank of America's APLT Position: Q1 2026 in Review
Bank of America sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 3,109 shares — an estimated $311 sold.
Bank of America first reported a position in APLT in Q3 2019 and held it in 26 quarters. The position peaked at $2.68M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Bank of America reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 3,109 Applied Therapeutics shares in Q1 2026, an estimated $311.
- Bank of America first reported a position in Applied Therapeutics in Q3 2019 and held it in 26 quarters.
- Bank of America's Applied Therapeutics position peaked at $2.68M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.